Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus (CMV) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00521287
What this trial is testing

Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection

Who this might be right for
Neoplasms
Mackay Memorial Hospital 150
Not applicableStudy completedNCT00815165
What this trial is testing

Cytomegalovirus Cell-Mediated Immunity

Who this might be right for
Cytomegalovirus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 165
Post-approval studies (Phase 4)WithdrawnNCT04936971
What this trial is testing

Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response

Who this might be right for
Kidney TransplantationCytomegalovirus Infections
Edoardo Melilli
Testing effectiveness (Phase 2)Study completedNCT02396134
What this trial is testing

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 61
Not applicableUnknownNCT03146208
What this trial is testing

Role of Endothelial Biomarkers in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseDiabetes MellitusCytomegalovirus Infections
Assiut University 54
Not applicableStudy completedNCT00006314
What this trial is testing

Cytomegalovirus Spread and Reactivation in Blood Cells

Who this might be right for
Blood DiseaseCytomegalovirus Infections
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT06568055
What this trial is testing

Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom

Who this might be right for
Cytomegalovirus (CMV)
Takeda 330
Not applicableStudy completedNCT00000593
What this trial is testing

Viral Activation Transfusion Study (VATS)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood TransfusionCytomegalovirus Infections+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT00002025
What this trial is testing

Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00881517
What this trial is testing

Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection

Who this might be right for
Cytomegalovirus Infection
Fondazione IRCCS Policlinico San Matteo di Pavia 124
Large-scale testing (Phase 3)Study completedNCT00001082
What this trial is testing

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 505
Not applicableStudy completedNCT00002135
What this trial is testing

An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Early research (Phase 1)Study completedNCT02826798
What this trial is testing

Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults

Who this might be right for
Cytomegalovirus Infections
VBI Vaccines Inc. 128
Not applicableStudy completedNCT00001089
What this trial is testing

HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Testing effectiveness (Phase 2)Study completedNCT00002437
What this trial is testing

The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Gilead Sciences 48
Large-scale testing (Phase 3)Study completedNCT00411645
What this trial is testing

Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients

Who this might be right for
Cytomegalovirus Infections
Shire 681
Not applicableStudy completedNCT00005496
What this trial is testing

Inflammation, Infection, and Future Cardiovascular Risk

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseCerebrovascular Accident+9 more
National Heart, Lung, and Blood Institute (NHLBI)
Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Not applicableStudy completedNCT00005274
What this trial is testing

Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)

Who this might be right for
Acquired Immunodeficiency SyndromeLung DiseasesCardiovascular Diseases+6 more
National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Next Page